Dynavax Technologies reported 765K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Adma Biologics ADMA:US 2.27K 30.8K
Biogen BIIB:US 12.6M 9.7M
BioMarin Pharmaceutical BMRN:US 2.5M 685K
Chimerix CMRX:US -21000 25K
Dynavax Technologies DVAX:US 765K 504K
Idera Pharmaceuticals IDRA:US 42K 39K
Nektar Therapeutics NKTR:US 1.1M 701K
Pfizer PFE:US 30M 16M
Sarepta Therapeutics SRPT:US 2.41M 2.24M
Vertex Pharmaceuticals VRTX:US 10.8M 9.2M